Follow
Vera Golder
Title
Cited by
Cited by
Year
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ...
Arthritis research & therapy 19, 1-11, 2017
1332017
Ankylosing spondylitis: an update
V Golder, L Schachna
Australian family physician 42 (11), 780-784, 2013
1312013
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
V Golder, R Kandane-Rathnayake, M Huq, HT Nim, W Louthrenoo, ...
The Lancet Rheumatology 1 (2), e95-e102, 2019
922019
Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic
V Golder, K Connelly, M Staples, E Morand, A Hoi
Lupus 22 (13), 1425-1430, 2013
772013
Discordance of patient and physician health status concerns in systemic lupus erythematosus
V Golder, JJY Ooi, AS Antony, T Ko, S Morton, R Kandane-Rathnayake, ...
Lupus 27 (3), 501-506, 2018
722018
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
S Oon, M Huq, V Golder, PX Ong, EF Morand, M Nikpour
Annals of the Rheumatic Diseases 78 (5), 629-633, 2019
612019
Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort
V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ...
Arthritis research & therapy 18, 1-9, 2016
562016
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study
D Apostolopoulos, R Kandane-Rathnayake, W Louthrenoo, SF Luo, ...
The Lancet Rheumatology 2 (1), e24-e30, 2020
542020
Systemic lupus erythematosus: an update.
V Golder, A Hoi
The Medical Journal of Australia 206 (5), 215-220, 2017
482017
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study
V Golder, R Kandane-Rathnayake, M Huq, W Louthrenoo, SF Luo, ...
The Lancet Rheumatology 1 (2), e103-e110, 2019
472019
Treatment targets in SLE: remission and low disease activity state
V Golder, MWP Tsang-A-Sjoe
Rheumatology 59 (Supplement_5), v19-v28, 2020
442020
Development of the Asia Pacific lupus collaboration cohort
R Kandane‐Rathnayake, V Golder, W Louthrenoo, SF Luo, YJ Jan Wu, ...
International journal of rheumatic diseases 22 (3), 425-433, 2019
322019
Lupus low disease activity state and reduced direct health care costs in patients with systemic lupus erythematosus
AL Yeo, R Koelmeyer, R Kandane‐Rathnayake, V Golder, A Hoi, M Huq, ...
Arthritis Care & Research 72 (9), 1289-1295, 2020
282020
Autonomic cardiovascular control in hypotensive critically ill preterm infants is impaired during the first days of life
V Golder, M Hepponstall, SR Yiallourou, A Odoi, RSC Horne
Early human development 89 (6), 419-423, 2013
282013
‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study
R Kandane-Rathnayake, W Louthrenoo, A Hoi, SF Luo, YJJ Wu, YH Chen, ...
Arthritis Research & Therapy 24 (1), 70, 2022
242022
Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study
V Golder, M Huq, K Franklyn, A Calderone, A Lateef, CS Lau, ALH Lee, ...
Seminars in arthritis and rheumatism 46 (6), 798-803, 2017
212017
Disseminated enteroviral infection associated with obinutuzumab
C Dendle, M Gilbertson, TM Korman, V Golder, E Morand, S Opat
Emerging Infectious Diseases 21 (9), 1661, 2015
212015
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
EF Morand, G Abreu, RA Furie, V Golder, R Tummala
Annals of the Rheumatic Diseases 82 (5), 639-645, 2023
192023
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study
R Kandane-Rathnayake, V Golder, W Louthrenoo, YH Chen, J Cho, ...
The Lancet Rheumatology 4 (12), e822-e830, 2022
192022
Clinician-reported outcome measures in lupus trials: a problem worth solving
K Connelly, V Golder, R Kandane-Rathnayake, EF Morand
The Lancet Rheumatology 3 (8), e595-e603, 2021
172021
The system can't perform the operation now. Try again later.
Articles 1–20